Medical specialists from Norway tagged as investigators in clinical trials studying Lymphoma, Large B-Cell, Diffuse
Total 12 results
-
Anders EngebretsenSeen in:
- Oslo, Akershus University Hospital
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Arne KolstadSeen in:
- Innlandet, Sykehuset Innlandet
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Dlawer BarzenjeSeen in:
- Grålum, Kalnes Hospital (Østfold)
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Hanne BersvendsenSeen in:
- Tromsø, University Hospital of North Norway
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Harald HolteSeen in:
- Oslo, Oslo University Hospital
Trials:- NCT03293173 (Principal Investigator)
Conditions: -
Julian HamfjordSeen in:
- Oslo, Avd. for Kreftbehandling, Oslo universitetssykehus
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Marit RindeSeen in:
- Tønsberg, Sykehuset i Vestfold
Trials:- NCT04332822 (Principal Investigator)
Conditions: -
Martin MaisenhölderSeen in:
- Tromsø, Dept. of Oncology, Universitetssykehuset i Nord-Norge HF
Trials:- NCT03293173 (Principal Investigator)
Conditions: -
Öystein FlugeSeen in:
- Bergen, Dept. of Oncology, Helse Bergen HF Haukeland sykehus
- Bergen, Haukeland Universitetshospital
Trials:- NCT04332822 (Principal Investigator)
- NCT03293173 (Principal Investigator)
-
Peter MeyerSeen in:
- Stavanger, Dept. of Haematology and Oncology, Helse Stavander HF sykehuset
Trials:- NCT03293173 (Principal Investigator)
Conditions: -
Unn Merete FagerliSeen in:
- Trondheim, Dept of Oncology, St. Olavs hospital HF
- Trondheim, Kreftklinikken, St Olavs Hospital
Trials:- NCT04332822 (Principal Investigator)
- NCT03293173 (Principal Investigator)
-
Waleed Majeed MohammedSeen in:
- Stavanger, Avdeling for Blod- og Kreftsykdommer, Stavanger Universitetssykehus
Trials:- NCT04332822 (Principal Investigator)
Conditions:
Clinical Trials on Lymphoma, Large B-Cell, Diffuse
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
National Cancer Institute (NCI)WithdrawnDiffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Cell of Origin